Renal function and outcomes in pulmonary arterial hypertension: a French Pulmonary Hypertension Registry study

Le résumé fourni par la source

Background Renal impairment is frequent in pulmonary arterial hypertension (PAH), yet renal function is not currently accounted for in the European Society of Cardiology (ESC)/European Respiratory Society (ERS) risk stratification tools. We investigated whether renal function provides independent prognostic information in PAH after adjustment for ESC/ERS risk score. Methods We conducted a retrospective analysis of the French Pulmonary Hypertension (PH) Network registry. Estimated glomerular filtration rate (eGFR) was calculated using the 2021 CKD-EPI equation. Renal dysfunction prevalence (eGFR <60 mL·min −1 ·1.73 m −2 ) was assessed in patients with PAH (n=3383). Time-to-event analyses for transplant-free survival were performed using Cox models adjusted for age, sex and ESC/ERS risk scores at baseline and at 3–12 months of follow-up. Results Renal dysfunction (eGFR <60 mL·min −1 ·1.73 m −2 ) was present in 28% of patients with PAH. Baseline eGFR <45 mL·min −1 ·1.73 m −2 was independently associated with reduced transplant-free survival in multivariable analysis. At 3–12 months of follow-up, eGFR <60 mL·min −1 ·1.73 m −2 predicted adverse outcomes in multivariable models (HR 1.25; 95% CI 1.04–1.50; p=0.018). Among patients with preserved baseline renal function, a relative decline in eGFR of ≥10% was independently associated with a higher risk of death or lung transplantation. Conclusions Baseline renal impairment and subsequent deterioration in renal function are independently associated with poorer transplant-free survival in PAH, beyond ESC/ERS risk stratification. These findings support consideration of renal function in prognostic assessment of patients with PAH.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.